MedPath

A clinical trial to study the effect of two methods of nasya in patients with chronic sinusitis

Phase 3
Not yet recruiting
Conditions
Chronic sinusitis, unspecified, (2) ICD-10 Condition: J329||Chronic sinusitis, unspecified. Ayurveda Condition: DUSHTAPRATISYAYAH,
Registration Number
CTRI/2021/06/034121
Lead Sponsor
VPSV AYURVEDA COLLEGE KOTTAKKAL
Brief Summary

This study is a randomised, parallel group trial comparing the effectiveness of alternate day nasya with tulasipatra svarasa and anutaila with alternate day nasya with anutaila in chronic sinusitis for 7 days in a total 42 patients in India. The primary outcome of this study is to assess Rhinisinusitis disability index, Visual analogue scale, Scale of scoring of symptoms for 22 days. Assessment of event evaluation scale and  samyak nasya lakshana for 7 days and outcome will be published in the form of dissertation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
42
Inclusion Criteria

1.Eligible for nasya 2.Participants with informed consent.

Exclusion Criteria
  • 1.Blood stained nasal discharge 2.Nasal polyp 3.
  • History of polypectomy and sinus surgery within 3 months 4.
  • Other known systemic diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Collected data will be assessed using Rhinosinusitis Disability Index, Visual Analogue Scale and Scale for scoring of symptoms (before trial, after trial and after follow up) for 22 days and Event evaluation scale and Samyak nasya lakṣaṇa (on each day of nasya) for 7 days and outcome will be presented in the form of dissertation.22 days
Secondary Outcome Measures
NameTimeMethod
Event evaluation scale and Samyak nasya lakṣaṇa (on each day of nasya) for 7 days7 days

Trial Locations

Locations (1)

VPSV AYURVEDA COLLEGE HOSPITAL

🇮🇳

Malappuram, KERALA, India

VPSV AYURVEDA COLLEGE HOSPITAL
🇮🇳Malappuram, KERALA, India
REMYA T M
Principal investigator
9447378935
drremyatm@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.